Clinical Trial Update: Maximal Tumor Eradication for Oligometastatic Prostate Cancer [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial investigating maximal tumor eradication for oligometastatic prostate cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: RenJi Hospital | Conditions: Oligometastatic Prostate Cancer | Phase 2, Phase 3 | Status: RECRUITING